G. Braslawsky

发表

Future of monoclonal antibodies in the treatment of hematologic malignancies.

M. Reff, K. Hariharan, G. Braslawsky, 2002, Cancer control : journal of the Moffitt Cancer Center.

Parametric analysis of histograms measured in flow cytometry.

R E Hand, R. Hand, R C Mann, 1983, Cytometry.

Changes in DNA content of rat tracheal epithelial cells during neoplastic progression in vitro.

P. Nettesheim, K. Flynn, G. Braslawsky, 1982, Carcinogenesis.

Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.

T. Kaneko, G. Spitalny, K. Fitzgerald, 1990, Cancer research.

Synthesis and antitumor activity of the immunoconjugate BR96-Dox

P. Trail, K. Hellström, I. Hellström, 1996 .

New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicity.

T. Kaneko, J. Knipe, D. Vyas, 1991, Bioconjugate chemistry.

Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.

P. Trail, D. King, M. Zoeckler, 1992, Cancer research.

Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.

P. Trail, T. Doyle, I. Hellstrom, 1997, Cancer research.

Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxin.

J. Brown, S. Gawlak, C. Siegall, 1992, Bioconjugate chemistry.

Determination of immunoreactivity of doxorubicin antibody immunoconjugates by a Le(y) competitive RIA.

J. Brown, G. Braslawsky, D. Willner, 1992, Bioconjugate chemistry.

Antibody therapy of non-Hodgkin's B-cell lymphoma

C. White, P. Chinn, N. Hanna, 2003, Cancer Immunology, Immunotherapy.

Direct binding of radioiodinated monoclonal antibody to tumor cells: significance of antibody purity and affinity for drug targeting or tumor imaging.

S. Kennel, L. Foote, P. Lankford, 1983, Hybridoma.

Homodimeric forms of bombesin act as potent antagonists of bombesin on Swiss 3T3 cells.

P. Kiener, S. Gawlak, R. Greenfield, 1991, Growth factors.

Pharmacokinetics and tumor localization of (111)in-labeled HuCC49DeltaC(H)2 in BALB/c mice and athymic murine colon carcinoma xenograft.

J. Schlom, S. Kashmiri, T. Kazules, 2006, Cancer biotherapy & radiopharmaceuticals.

Combined use of AFM and X-ray diffraction to analyze crystals of an engineered, domain-deleted antibody.

S. Larson, A. McPherson, Y. Kuznetsov, 2005, Acta crystallographica. Section D, Biological crystallography.

Induction of differentiation of human promyelocytic leukemia (HL-60) cells by teleocidin and phorbol-12-myristate-13-acetate.

E. Huberman, G. Braslawsky, M. Callaham, 1982, Carcinogenesis.

Specificity of Tumor Cell Killing Immunoconjugates Compared with Free Adriamycin and Antitumor Activity of Adriamycin ( Hydrazone-linked ) Updated

Kaneko, R. Greenfield, G. Braslawsky, 2006 .

Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.

T. Kaneko, R. Greenfield, G. Braslawsky, 1990, Cancer research.

Granulocyte‐macrophage colony‐stimulating factor plays a role in the functional activity of mast cells

I. Bursuker, R. Meade, R. Greenfield, 1993, Journal of leukocyte biology.

Optimization of immunotherapy with adriamycin(hydrazone)-immunoconjugates in human B-lymphoma xenografts

S. Gawlak, G. Spitalny, A. Daues, 1991 .

(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.

P. Trail, T. Kaneko, H. D. King, 1993, Bioconjugate chemistry.

Monoclonal antibodies directed against rat tracheal epithelial cells transformed in vitro

S. Kennel, P. Nettesheim, R. Hand, 1984, International journal of cancer.

Detection of tumor antigens by syngeneic antiserum on in vitro, transformed tracheal epithelial cell line 2‐10‐1

S. Kennel, P. Nettesheim, G. Braslawsky, 1982, International journal of cancer.

Syngeneic immune response to rat tracheal epithelial cells transformed in vitro by N-methyl-N-nitro-N-nitrosoguanidine.

S. Kennel, P. Nettesheim, G. Braslawsky, 1981, British Journal of Cancer.

Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity

Mary Edson, Robert S. Greenfield, Takushi Kaneko, 2005, Cancer Immunology, Immunotherapy.

Tumor bound immunoglobulins: The relationship between the in vivo coating of tumor cells by potentially cytotoxic anti‐tumor antibodies, and the expression of immune complex receptors

I. Witz, G. Braslawsky, M. Ran, 1976, International journal of cancer.

Phenotypic changes in epithelial cell population undergoing neoplastic transformation in vitro.

S. Kennel, P. Nettesheim, G. Braslawsky, 1983, Progress in nucleic acid research and molecular biology.

The structure of an antitumor C(H)2-domain-deleted humanized antibody.

S. Larson, A. McPherson, J. Day, 2005, Journal of molecular biology.

humanized antibody

S. Larson, A. McPherson, J. Day, 2005 .

Receptors for immune complexes on cells within a non-lymphoid murine tumor.

I. Witz, A. Frensdorff, G. Braslawsky, 1976, Journal of immunology.

The induction of cytotoxic T cells and tumor regression by soluble antigen formulation.

Santanu Raychaudhuri, A. Black, K. Hariharan, 1995, Cancer research.

Receptors for immune complexes on cells within a polyoma virus‐induced murine sarcoma

I. Witz, D. Serban, G. Braslawsky, 1976, European journal of immunology.

Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen.

M. Ross, J. Murray, A. Buzaid, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Purification et synthese preferentielle de molecules de liaison

J. Hopp, G. Braslawsky, Scott Glaser, 2004 .

Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees.

R W Sweet, M. Doyle, R. Sweet, 2001, Clinical immunology.